Canoe Financial LP Has $8.06 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Canoe Financial LP raised its holdings in Colgate-Palmolive (NYSE:CL) by 5.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 88,646 shares of the company’s stock after buying an additional 4,200 shares during the quarter. Canoe Financial LP’s holdings in Colgate-Palmolive were worth $8,059,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Folger Nolan Fleming Douglas Capital Management Inc. grew its stake in shares of Colgate-Palmolive by 6.1% in the fourth quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 5,714 shares of the company’s stock worth $519,000 after acquiring an additional 330 shares during the last quarter. Arthur M. Cohen & Associates LLC boosted its holdings in Colgate-Palmolive by 8.2% in the 4th quarter. Arthur M. Cohen & Associates LLC now owns 2,650 shares of the company’s stock valued at $241,000 after purchasing an additional 200 shares during the period. Brooklyn Investment Group grew its position in Colgate-Palmolive by 7.9% in the 4th quarter. Brooklyn Investment Group now owns 5,564 shares of the company’s stock worth $506,000 after purchasing an additional 405 shares during the last quarter. Sax Wealth Advisors LLC raised its position in shares of Colgate-Palmolive by 432.0% during the fourth quarter. Sax Wealth Advisors LLC now owns 22,764 shares of the company’s stock valued at $2,069,000 after buying an additional 18,485 shares during the last quarter. Finally, Somerset Trust Co lifted its stake in shares of Colgate-Palmolive by 3.6% in the fourth quarter. Somerset Trust Co now owns 24,859 shares of the company’s stock valued at $2,260,000 after buying an additional 863 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $88.79 on Friday. The business’s fifty day moving average is $92.27 and its two-hundred day moving average is $97.78. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The firm has a market cap of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.25%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CL shares. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday. Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Finally, Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.